- Country: South Korea
- Summary: [academic / Long-term] Esbl Generation Local Documentary Fosfomycin Therapeutic Effect in Local Area Infection
- KRT Ref No: 64933029
- Deadline: 12 Apr 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 45454545445454546
- Notice Type: Tender
- Document Ref. No.: 20220346647-00
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- [Academic / Long-term] ESBL Generation Local Area Study in Local Division Infection Study on Fosfomycin Therapeutic Effect Reference Number: Disease Administration National Health Research Institute of Health Research Institute 2022-87
Assignment Budget: 500,000,000 won
Estimated price: 454,545,454 won (VAT: 45,454,546)
Bidding date: 2022/04/05 10:00:00:00
Bidding Finish: 2022/04/12 10:00:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN[academic / Long-term] Esbl Generation Local Documentary Fosfomycin Therapeutic Effect in Local Area Infection - Korea Tender
The NATIONAL HEALTH RESEARCH INSTITUTE OF DISEASE ADMINISTRATION, a Government sector organization in South Korea, has announced a new tender for [academic / Long-term] Esbl Generation Local Documentary Fosfomycin Therapeutic Effect in Local Area Infection. This tender is published on KoreaTenders under KRT Ref No: 64933029 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-04-12.
The estimated tender value is KRW 45454545445454546, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
